A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
about
Alterations in Mitochondrial Quality Control in Alzheimer's DiseaseShift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventionsNeuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glassTargeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunitiesParkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brainsPermeability transition pore-mediated mitochondrial superoxide flashes mediate an early inhibitory effect of amyloid beta1-42 on neural progenitor cell proliferation.Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African AmericansEstrogen: a master regulator of bioenergetic systems in the brain and bodyMitochondrial DNA sequence variation associated with dementia and cognitive function in the elderly.Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer's disease.Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR-743aTruncated tau and Aβ cooperatively impair mitochondria in primary neurons.Tau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neuronsFunctional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast.Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.New insights in the amyloid-Beta interaction with mitochondriaThe mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease.Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders.Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease.Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases.Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease.A Mitocentric View of Alzheimer's Disease.Digitoflavone provokes mitochondrial biogenesis in PC12 cells: A protective approach to oxidative stress.Blood-Based Bioenergetic Profiling Reflects Differences in Brain Bioenergetics and Metabolism.Impaired axonal retrograde trafficking of the retromer complex augments lysosomal deficits in Alzheimer's disease neurons.Alterations in Cerebral Cortical Glucose and Glutamine Metabolism Precedes Amyloid Plaques in the APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease.Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease.Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease.Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer's Disease Prevention.
P2860
Q26768215-78D6B190-71F6-4E1A-9C47-97C2C9C25312Q26830740-FC5EC22A-CB2E-4215-A723-1D24C8F50F38Q27015785-90F79192-7FC8-490B-86D7-AC82F5CA08F5Q27338799-946EBA6F-7729-4AAD-ACF9-D34E663BF748Q28392337-58C65502-1307-49B5-A940-3176B0BF49D4Q30573641-40CBE525-8F9F-4E97-9D05-CD012DC78AC7Q33585950-C2D3B44C-2B0A-405C-A7F7-6E671433EA10Q33603868-148267C2-B0F3-4732-ABCE-2B0147733DA2Q33623924-79B7EE5D-7DD4-4AF9-B59A-2FCB46B0B482Q34140769-9395E7D4-6FA0-48E7-843E-AE8BBCC433F1Q34407220-C3B7BB99-BBEA-46DE-929E-2870AF1E174FQ34759070-677BAA72-526E-440A-9E09-64AE9AA3D046Q35103403-53E758B5-42FC-4262-9076-11FB47AB71CDQ35119001-4D899311-7E4E-4169-8730-8BFF288602DEQ35642271-94FEA46D-C704-448E-BE14-BCD604D96F1EQ35763361-88BE5D18-602B-4CD2-BC93-C88AE0C9E74DQ35846798-699B2CC4-D0F6-4775-B198-4F64E9B2FA7FQ35864854-7F87AD69-00B0-4E4C-92CD-502E51EDE034Q35908404-B969ED90-392C-404B-8877-5AA2DA82EECCQ36460635-2AD225EC-34F7-4F64-BCD1-A70689167D1CQ36689520-55A54C84-FE0D-46E2-BD25-CB648AE5A26FQ37675866-37B5A490-BC2B-438A-979E-9CE4ED118E13Q37826364-AAD41CF5-5843-4BB4-9379-8F504F964265Q38883083-40966C09-E4E5-4314-8392-C477BD9B83FCQ38970508-12A99A6B-A93F-47CB-AC8A-7FF5CC268A25Q46746268-A6696EB6-1895-4ACE-BC67-AE66A84C2F9AQ47231097-0F36B07A-6EB1-40B3-9EEE-8970409C6346Q47707234-E8F49669-0157-4833-BBE4-6DB4B11DB2FBQ48054389-96957F13-C6AD-422D-A626-C91249A22C03Q49940144-248D6B5B-E4D1-4142-BEF1-8CC0B4E0250BQ50197771-3780D18B-1075-4518-BD1B-4535F8C9608CQ55090853-33AD3D4B-2789-44A4-8144-C018DBD30833
P2860
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
@ast
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
@en
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
@nl
type
label
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
@ast
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
@en
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
@nl
prefLabel
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
@ast
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
@en
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
@nl
P2860
P356
P1476
A mitocentric view of Alzheimer's disease suggests multi-faceted treatments
@en
P2093
Gary E Gibson
Qingli Shi
P2860
P304
P356
10.3233/JAD-2010-100336
P478
20 Suppl 2
P577
2010-01-01T00:00:00Z